-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
alain moreau
-
SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis, 2025, Moreau, Fluge, Mella et al
Abstract: Background Sphingomyelin phosphodiesterase acid-like 3B (SMPDL3B) is emerging as a potential biomarker and therapeutic target in myalgic encephalomyelitis (ME), a complex multisystem disorder characterized by immune dysfunction, metabolic disturbances, and persistent fatigue. This...- Nightsong
- Thread
- alain moreau fluge lipid rafts me/cfs mella monocytes oestrogen smpdl3b sphingolipids sphingomyelin tlr-3 tlr-4
- Replies: 57
- Forum: ME/CFS research
-
2023 IIMEC15 - Alain Moreau
YouTube: IIMEC15 07 Professor Alain Moreau 15th Invest in ME Research International ME Conference 2023 Discussion of potential biomarkers in ME/LC subgroups. References upcoming, unpublished work. Highlighted time-stamps — 9:07 MicroRNAs 18:18 SMPDL3B 27:03 FGF-21 SMPDL3B is Sphingomyelin...- SNT Gatchaman
- Thread
- alain moreau biomarker fgf21 micro-rna moreau smpdl3b
- Replies: 21
- Forum: ME/CFS research news
-
Healthy Debate: Groundbreaking research into ME/CFS a pandemic ‘silver lining’
Groundbreaking research into ME/CFS a pandemic ‘silver lining’ https://healthydebate.ca/2022/12/topic/research-mecfs-pandemic-silver-lining/- ahimsa
- Thread
- alain moreau long covid me/cfs micro-rna open medicine foundation research
- Replies: 8
- Forum: General ME/CFS news